Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Viral vector |
Clinical data | |
Other names | VXA-CoV2-1, VXA-CoV2-1.1-S |
Routes of administration | Oral |
Identifiers | |
CAS Number |
Part of a series on the |
COVID-19 pandemic |
---|
|
COVID-19 portal |
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart.[2][3][4]